Persistent Infection clinical trials

The registry lists 44 studies for Persistent Infection across more than 10 countries. 5 are recruiting or about to start. 16 of them are mainly about Persistent Infection (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30.

Get an email when these change. Save the Persistent Infection studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 22
Status unknown: 12
Active, not recruiting: 4
Recruiting: 3
Enrolling by invitation: 2
Withdrawn: 1

Phase

Phase 4: 8
Phase 3: 4
Phase 1: 3
Phase 2: 2

Where

China: 13
France: 5
United States: 5
Italy: 4
Israel: 2
Brazil: 2

Who runs them

Jun Zhang (5) · Hospices Civils de Lyon (2) · Xiamen University (2) · New Discovery LLC (2) · Clarametyx Biosciences, Inc. (1) · São Paulo State University (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · University of California, San Francisco (1)

What is being tested here

Drugs under test in Persistent Infection studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Escherichia coli	0	0	1
Maraviroc	0	0	1
Dolutegravir	0	0	1
Dendritic Cell Vaccine	0	0	1
Auranofin	0	0	1
Niacinamide	0	0	1
Telbivudine	0	0	1
Lamivudine	0	0	1
Tenofovir	0	0	1
Tobramycin	0	0	1

Coming up

0phase 3 studies under way

4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Nov 2026NWRD09 for Persistent Cervical HPV16 Infection · Newish Biotech (Wuxi) Co., Ltd.
Dec 2026Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls · Xiamen University
Jan 2027Susceptibility to Infectious Diseases in Obesity · Azienda Ospedaliero Universitaria Maggiore della Carita
Aug 2027Evaluation of Different Medicaments in the Management of Necrotic Primary Molars by Lesion Sterilization and Tissue Repair · Ain Shams University

Who these studies take

Of the 3 Persistent Infection studies recruiting now, 1 (33%) set no upper age limit and 2 (67%) stop at 75 or younger. 1 (33%) take children under 18. 1 (33%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	1 (33%)	1 (33%)
18	2 (67%)	2 (67%)
30	2 (67%)	2 (67%)
40	2 (67%)	2 (67%)
50	3 (100%)	2 (67%)
65	3 (100%)	2 (67%)
75	1 (33%)	1 (33%)
85	1 (33%)	1 (33%)

Across all 44 studies, recruiting or not: 59% stop at 75 or younger and 52% at 65; 25% take children; 34% are for women only and 2% for men only; 39% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 44 of 44. search them.